CS logo
small CS logo
Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische

Kassel, Germany
Neurologe in Kassel, Hessen

About Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische


"Christoph Lassek, Dr. med. Annette Ammerbach, Dr. med. Andreas Fetzer, Michael Fischer, Dr. med. Florian Heinen - Fachärzte für Neurologie"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Biogen
2
Hoffmann-La Roche
2
Total Rows: 2

Clinical Trials at Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische


During the past decade, Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111000011000000000000Started TrialsCompleted Trails20152016201720182019202000.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
2015-08-13
2019-08-08
Terminated
1,653
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
2020-03-02
2025-02-03
Active, not recruiting
1,696

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsBiogen: 2Biogen: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische


According to Clinical.Site data, the most researched conditions in "Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische" are "Alzheimer's Disease" (2 trials) and "Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische" in a lesser frequency.

Clinical Trials Intervention Types at Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische


Most popular intervention types in "Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (2 trials), "Aducanumab" (1 trials), "Aducanumab (BIIB037)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische


The vast majority of trials in "Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische" are 4 trials for "All" genders.

Clinical Trials Status at Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische


Currently, there are NaN active trials in "Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Neurologische Gemeinschaftspraxis Kassel und Vellmar, Ch. Lassek, Dres. Ammerbach, Fetzer, M. Fische, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 2Active, not recruiting: 2Completed: 1Completed: 1Terminated: 1Terminated: 1